Your browser doesn't support javascript.
loading
Whole-brain modeling of the differential influences of amyloid-beta and tau in Alzheimer's disease.
Patow, Gustavo; Stefanovski, Leon; Ritter, Petra; Deco, Gustavo; Kobeleva, Xenia.
Afiliação
  • Patow G; ViRVIG, Universitat de Girona, Girona, Spain. gustavo.patow@udg.edu.
  • Stefanovski L; Department of Information and Communication Technologies, Universitat Pompeu Fabra, Center for Brain and Cognition, Computational Neuroscience Group, Barcelona, Spain. gustavo.patow@udg.edu.
  • Ritter P; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Deco G; Department of Neurology with Experimental Neurology, Brain Simulation Section, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, 10117, Germany.
  • Kobeleva X; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
Alzheimers Res Ther ; 15(1): 210, 2023 12 05.
Article em En | MEDLINE | ID: mdl-38053164
ABSTRACT

BACKGROUND:

Alzheimer's disease is a neurodegenerative condition associated with the accumulation of two misfolded proteins, amyloid-beta (A[Formula see text]) and tau. We study their effect on neuronal activity, with the aim of assessing their individual and combined impact.

METHODS:

We use a whole-brain dynamic model to find the optimal parameters that best describe the effects of A[Formula see text] and tau on the excitation-inhibition balance of the local nodes.

RESULTS:

We found a clear dominance of A[Formula see text] over tau in the early disease stages (MCI), while tau dominates over A[Formula see text] in the latest stages (AD). We identify crucial roles for A[Formula see text] and tau in complex neuronal dynamics and demonstrate the viability of using regional distributions to define models of large-scale brain function in AD.

CONCLUSIONS:

Our study provides further insight into the dynamics and complex interplay between these two proteins, opening the path for further investigations on biomarkers and candidate therapeutic targets in-silico.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Alzheimer Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Alzheimer Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article